SABS
SAB Biotherapeutics Inc
3.20$
+0.2%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +1,504.8% | +10.2% | -60.7% | -90.6% | -40.9% | -100.0% | |
| – | – | – | +99.0% | +13.8% | +28.0% | -35.7% | |
| – | +1,504.8% | +7.2% | -65.2% | -107.3% | – | – | |
| – | +248.0% | +104.9% | -36.3% | -54.7% | +82.7% | +13.9% | |
| – | +65.3% | +152.3% | -4.1% | +45.3% | -41.3% | +4.4% | |
| – | +186.3% | +109.4% | -31.8% | -26.2% | +7.9% | +16.3% | |
| – | – | -165.2% | – | – | – | – | |
| – | +9.5% | -37.2% | +2.4% | +4.5% | +1.0% | -24.4% | |
| – | – | -185.2% | – | – | – | – | |
| – | +9.8% | -36.6% | -91.5% | -100.0% | – | – | |
| – | – | -185.2% | – | – | – | – | |
| – | – | -171.9% | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.